Laws Forbidding Pregnancy Discrimination in Substance Use Disorder Treatment Are Not Associated With Treatment Access.
Laws Forbidding Pregnancy Discrimination in Substance Use Disorder Treatment Are Not Associated With Treatment Access.
复制标题
在药物使用障碍治疗中禁止怀孕歧视的法律与治疗获取无关。
DOI：
10.1097/adm.0000000000000897
复制
发表时间：
2022-05-01
影响因子：
5.5
通讯作者：
Patrick SW
中科院分区：
文献类型：
--
作者：
Davis CS;McNeer E;Patrick SW
To determine if state laws that forbid substance use disorder (SUD) treatment providers from refusing services based on pregnancy are associated with improved ability to secure an initial appointment for opioid use disorder treatment with methadone and buprenorphine. Ten states in which a “secret shopper” study was conducted were stratified based on whether they have a law that forbids SUD treatment providers from refusing to treat individuals because of pregnancy. We tested for differences in percent of pregnant vs. non-pregnant callers offered an initial appointment for medication for OUD (MOUD) treatment between states with a law and those without. We also tested for differences in acceptance based on caller insurance type. Four states with 1,461 callers had relevant laws; six states with 2,495 callers did not. None of the laws apply to all providers. In both groups of states, non-pregnant callers were significantly more likely to obtain a buprenorphine appointment (75.1% vs. 60.1% in states with a law, p<0.01; 73.1% vs. 62.3% in states without, p<0.01). No significant differences were found in methadone appointment access either between pregnant and non-pregnant callers or between pregnant callers in states with a law compared to those without. Laws that forbid providers from refusing to treat potential patients because they are pregnant were not associated with success in obtaining an initial appointment for MOUD treatment. States should consider expanding those laws to apply to all treatment providers and ensure that currently covered providers are in compliance.
